Literature DB >> 15313527

Evaluation of procalcitonin as a marker of infection in a nonselected sample of febrile hospitalized patients.

Patricia Muñoz1, Nuria Simarro, Marisa Rivera, Roberto Alonso, Luis Alcalá, Emilio Bouza.   

Abstract

The level of procalcitonin is undetectable in healthy individuals and slightly increased in viral infections and noninfectious inflammatory responses. It has been described to be notably increased in bacterial, parasitic, or fungal infections. Procalcitonin has been reported to be a reliable marker for severe bacterial infections, although it has mainly been studied in specific entities or in selected groups of patients. We prospectively determined the procalcitonin level in 103 unselected febrile hospitalized patients. Most of them had a proven (39) or probable bacterial infection (44). Procalcitonin was more frequently positive in bacteremic patients (p = 0.01), in patients with a proven bacterial infection (p < 0.01), and in those with a high sepsis score (p < 0.005), however; when cases with proven bacterial infection were considered as a reference, the sensitivity of the test was only 54% and the specificity 70%. Procalcitonin determination should not be included systematically in the screening of febrile hospitalized patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15313527     DOI: 10.1016/j.diagmicrobio.2004.04.002

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  5 in total

1.  Diagnostic value of procalcitonin in acutely hospitalized elderly patients.

Authors:  O Steichen; E Bouvard; G Grateau; S Bailleul; J Capeau; G Lefèvre
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-09-01       Impact factor: 3.267

2.  Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study.

Authors:  Shahin Gaïni; Ole Graesbøll Koldkjaer; Court Pedersen; Svend Stenvang Pedersen
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

3.  Procalcitonin as a biomarker for severe Plasmodium falciparum disease: a critical appraisal of a semi-quantitative point-of-care test in a cohort of travellers with imported malaria.

Authors:  Dennis A Hesselink; Jan-Steven Burgerhart; Hanna Bosmans-Timmerarends; Pieter Petit; Perry J J van Genderen
Journal:  Malar J       Date:  2009-09-01       Impact factor: 2.979

4.  Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study.

Authors:  Kristian Kofoed; Ove Andersen; Gitte Kronborg; Michael Tvede; Janne Petersen; Jesper Eugen-Olsen; Klaus Larsen
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

5.  Serum procalcitonin as a biomarker of bloodstream infection & focal bacterial infection in febrile patients.

Authors:  Janjam Harikrishna; Alladi Mohan; D P Kalyana Chakravarthi; Abhijit Chaudhury; B Siddhartha Kumar; K V S Sarma
Journal:  Indian J Med Res       Date:  2020-04       Impact factor: 2.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.